Autor: |
Mansour A; Department of Anesthesia and Critical Care, Pontchaillou, University Hospital of Rennes, France; Univ Rennes, CHU Rennes, Inserm, IRSET, UMR_S 1085, Rennes, France. Electronic address: alexandre.mansour@chu-rennes.fr., Mullier F; Hematology Laboratory, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Université catholique de Louvain, Centre Hospitalier Universitaire, Université catholique de Louvain (CHU UCL) Namur, Yvoir, Belgium; Institut de Recherche Expérimentale et Clinique, Pôle Mont, Université Catholique de Louvain, Yvoir, Belgium., Lecompte T; Department of Laboratory Hematology, Pontchaillou University Hospital of Rennes, Rennes, France; Department of Pharmacy, Namur Thrombosis and Hemostasis Center, Namur Research Institute for Life Sciences, University of Namur, Namur, Belgium; Vascular Medicine Department, University Hospital of Nancy, University of Lorraine, Nancy, France; University Hospital of Dijon Bourgogne, Dijon, France., de Maistre E; Service d'Hématologie Biologique, unité d'hémostase, CHU Dijon, Dijon, France., Gouin-Thibault I; Univ Rennes, CHU Rennes, Inserm, IRSET, UMR_S 1085, Rennes, France; Department of Hematology, Pontchaillou, University Hospital of Rennes, France., Hardy M; Hematology Laboratory, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Université catholique de Louvain, Centre Hospitalier Universitaire, Université catholique de Louvain (CHU UCL) Namur, Yvoir, Belgium; Institut de Recherche Expérimentale et Clinique, Pôle Mont, Université Catholique de Louvain, Yvoir, Belgium; Anesthesiology Department, CHU UCL Namur, Yvoir, Belgium. |
Abstrakt: |
Competing Interests: Declaration of competing interests A.M. received payments made to his institution from i-SEP for consulting fees and from LFB, Aguettant, Viatris, and Pfizer for lecture fees, all outside the submitted work. F.M. reports institutional fees from Stago, Werfen, Nodia, Roche Sysmex, and Bayer. He also reports speaker fees from Boehringer-Ingelheim, Bayer Healthcare, Bristol-Myers Squibb-Pfizer, Diagnostica Stago, Sysmex, and Aspen, all outside the submitted work. T.L., E.D.M., I.G.T., and M.H. have no competing interests to disclose. |